These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 25582520)

  • 41. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T
    Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
    de Boer HD; van Esmond J; Booij LH; Driessen JJ
    Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
    Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
    Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y
    Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recovery time after sugammadex reversal of rocuronium-induced muscle relaxation for electroconvulsive therapy is independent of cardiac output in both young and elderly patients.
    Kadoi Y; Nishida A; Saito S
    J ECT; 2013 Mar; 29(1):33-6. PubMed ID: 23052151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
    Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children.
    Ammar AS; Mahmoud KM; Kasemy ZA
    Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.
    Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE
    J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.
    Kim JE; Chun HR
    Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sugammadex is effective in reversing rocuronium in the presence of antibiotics.
    Hudson ME; Rietbergen H; Chelly JE
    BMC Anesthesiol; 2014; 14():69. PubMed ID: 25157214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex.
    Eleveld DJ; Kuizenga K; Proost JH; Wierda JM
    Anesth Analg; 2007 Mar; 104(3):582-4. PubMed ID: 17312212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
    Dahaba AA; Bornemann H; Hopfgartner E; Ohran M; Kocher K; Liebmann M; Wilfinger G; Metzler H
    Br J Anaesth; 2012 Apr; 108(4):602-6. PubMed ID: 22315331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of sugammadex in patients with a history of pulmonary disease.
    Amao R; Zornow MH; Cowan RM; Cheng DC; Morte JB; Allard MW
    J Clin Anesth; 2012 Jun; 24(4):289-97. PubMed ID: 22608583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.
    Rezonja K; Mars T; Jerin A; Kozelj G; Pozar-Lukanovic N; Sostaric M
    BMC Anesthesiol; 2016 Oct; 16(1):101. PubMed ID: 27765010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time course of rocuronium-induced neuromuscular block after pre-treatment with magnesium sulphate: a randomised study.
    Czarnetzki C; Lysakowski C; Elia N; Tramèr MR
    Acta Anaesthesiol Scand; 2010 Mar; 54(3):299-306. PubMed ID: 19919585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postoperative impairment of motor function at train-of-four ratio ≥0.9 cannot be improved by sugammadex (1 mg kg-1).
    Baumüller E; Schaller SJ; Chiquito Lama Y; Frick CG; Bauhofer T; Eikermann M; Fink H; Blobner M
    Br J Anaesth; 2015 May; 114(5):785-93. PubMed ID: 25586724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potency estimation of sugammadex for the reversal of moderate rocuronium-induced neuromuscular block: a non-randomized dose-response study.
    Kitajima O; Yamamoto M; Takagi S; Suzuki T
    J Anesth; 2020 Jun; 34(3):348-351. PubMed ID: 32095883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
    Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
    Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnesium sulphate effects on sugammadex reversal time - a reply.
    Germano Filho PA
    Anaesthesia; 2015 Dec; 70(12):1457-8. PubMed ID: 26558864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.